Acupuncture for Enhanced Recovery After Surgery in Patients Undergoing Laparoscopic Colorectal Cancer Resection

June 25, 2016 updated by: Gyung-Mo Son, Korean Medicine Hospital of Pusan National University

Background:

Patients who undergo laparoscopic surgical resection of colorectal cancer may experience various post-operative symptoms (e.g., pain, nausea and vomiting, and anxiety) and limitation of daily activities (e.g., walking capacity). There is also a risk of post-operative complications and a prolonged hospital stay due to complications. Patients who underwent surgical resection may have experienced chronic pain, anxiety/depression, or diminished quality of life. The physical, psychological, and functional aspects of patients' disorders imply the necessity of multidisciplinary care, including complementary or traditional medicines such as acupuncture. This study aims to assess whether acupuncture treatment, combined with an enhanced recovery program after surgery in an inpatient care setting is effective than only an enhanced recovery program after surgery.

Objective:

To assess the effectiveness and safety of acupuncture combined with an enhanced recovery program after surgery to reduce postoperative symptoms and improve functional recovery and the patients' quality of life.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kyung Sang South Province
      • Yangsan, Kyung Sang South Province, Korea, Republic of, 626770
        • National Clinical Research Centre for Korean Medicine, Korean Medicine Hospital, Pusan National University
      • Yangsan, Kyung Sang South Province, Korea, Republic of, 626770
        • Pusan National University Yangsan Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 71 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing elective laparoscopic surgery of colorectal cancer resection (right hemicolectomy, left hemicolectomy, anterior resection with primary anastomosis, and low anterior resection with loop ileostomy for fecal diversion)
  • Patients aged 18 to 75
  • American Society of Anesthesiologists Grade 1 to 2
  • Eastern Cooperative Oncology Group Grade 0 to 2
  • Written informed consents

Exclusion Criteria:

  • Pregnancy
  • Inflammatory bowel disease
  • Comorbidities that may affect outcomes of surgery (e.g., chronic kidney disease, chronic liver disease, cardiopulmonary failure, and diabetes with complications)
  • Resection of other organs for radical removal of colorectal cancer
  • Patients requiring enterolysis due to previous history of abdominal surgery
  • Obstructive colorectal cancer
  • Metastatic colorectal cancer
  • Cognitive impairment that may affect the patient's ability to complete the outcome assessments
  • Previous history of stroke
  • Previous history of sensitive reaction to acupuncture
  • Patients unable to cooperate with acupuncture treatments
  • Pacemaker implantation
  • Previous history of epilepsy
  • Patients who have received Korean medicine treatments (acupuncture, moxibustion, cupping, or herbal medicine) within 2 weeks
  • Patients who have participated in other trials within 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acupuncture
Manual and electroacupuncture

Points of Stomach 36 (ST36), Stomach 37 (ST37), Liver 3 (LR3), Large Intestine 11 (LI11), Large Intestine 4 (LI4), Spleen 6 (SP6), Spleen 4 (SP4) and Pericardium 6 (PC6) will be used. Electrical stimulation with alternating frequency of 2 to 100 Hz will be applied to the selected points (LI4 to LI11, ST36 to ST37, and bilateral SP6).

Rationale of acupuncture treatments will include both traditional theory of harmonizing gastrointestinal function and strengthening vital energy as well as modern experimental and clinical evidence of regulating gastrointestinal motility and other symptom managements. Treatments will be provided by qualified hospital staff (Korean medical doctors) with more than 10 years of clinical experience.

Active Comparator: Enhanced recovery program after surgery

Points of Stomach 36 (ST36), Stomach 37 (ST37), Liver 3 (LR3), Large Intestine 11 (LI11), Large Intestine 4 (LI4), Spleen 6 (SP6), Spleen 4 (SP4) and Pericardium 6 (PC6) will be used. Electrical stimulation with alternating frequency of 2 to 100 Hz will be applied to the selected points (LI4 to LI11, ST36 to ST37, and bilateral SP6).

Rationale of acupuncture treatments will include both traditional theory of harmonizing gastrointestinal function and strengthening vital energy as well as modern experimental and clinical evidence of regulating gastrointestinal motility and other symptom managements. Treatments will be provided by qualified hospital staff (Korean medical doctors) with more than 10 years of clinical experience.

An enhanced recovery program after surgery that was designed and is currently implemented by surgeons, anesthetists, dietitians, and nurses will be provided. The program includes preoperative education, early water/food intake, early mobilization, early removal of Foley catheter and drains, structured nursing care, and nutritional support.
Other Names:
  • fast-track recovery program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recovery of physical function
Time Frame: at 2 weeks after surgery
Recovery of physical function, as measured by the physical function domain of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) C30 instrument
at 2 weeks after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: at 4, 12, 24, 48, 72 hours after surgery, at 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, and at 4 weeks after surgery
Pain scores on a numeric rating scale. Score ranges from 0 (no pain at all) to 10 (the worst pain imaginable)
at 4, 12, 24, 48, 72 hours after surgery, at 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, and at 4 weeks after surgery
Time to first flatus
Time Frame: up to 1 week after surgery (an expected period of admission)
elapsed time after surgery
up to 1 week after surgery (an expected period of admission)
Time to tolerate soft diet
Time Frame: up to 1 week after surgery (an expected period of admission)
elapsed time after surgery
up to 1 week after surgery (an expected period of admission)
Time to first defecation
Time Frame: up to 1 week after surgery (an expected period of admission)
elapsed time after surgery
up to 1 week after surgery (an expected period of admission)
Time to independent walk
Time Frame: up to 1 week after surgery (an expected period of admission)
elapsed time after surgery
up to 1 week after surgery (an expected period of admission)
Number of insertions of nasogastric tube
Time Frame: up to 1 week after surgery (an expected period of admission)
number of insertions of nasogastric tube
up to 1 week after surgery (an expected period of admission)
Incidence of nausea/vomiting
Time Frame: up to 1 week after surgery (an expected period of admission)
number of nausea / vomiting reported by the patients
up to 1 week after surgery (an expected period of admission)
Time to first removal of Foley catheter
Time Frame: up to 1 week after surgery (an expected period of admission)
elapsed time after surgery
up to 1 week after surgery (an expected period of admission)
Number of reinsertions of Foley catheter
Time Frame: up to 1 week after surgery (an expected period of admission)
number of reinsertions of Foley catheter
up to 1 week after surgery (an expected period of admission)
Number of clean intermittent catheterizations
Time Frame: up to 1 week after surgery (an expected period of admission)
number of clean intermittent catheterizations
up to 1 week after surgery (an expected period of admission)
Quality of life measured by EORTC QLQ C30
Time Frame: at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgery
Quality of life measured by EORTC QLQ C30
at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgery
Patient's global assessment after surgery
Time Frame: at 4 weeks after surgery, at 12 weeks after surgery
Response options include very much improved, somewhat improved, no change, somewhat worsened, and very much worsened.
at 4 weeks after surgery, at 12 weeks after surgery
Use of medication
Time Frame: at 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgery
Use of analgesics, antiemetics and other medications after surgery
at 1 week after surgery (an expected day of discharge), at 2 weeks after surgery, at 4 weeks after surgery, and at 12 weeks after surgery
Anxiety and depression
Time Frame: at 2 weeks after surgery, at 4 weeks after surgery, at 12 weeks after surgery
Patients' anxiety and depression level measured by the Hospital Anxiety-Depression Scale
at 2 weeks after surgery, at 4 weeks after surgery, at 12 weeks after surgery
Postoperative complications
Time Frame: within 12 weeks after surgery
  • wound infection
  • urinary tract infection
  • urinary retention
  • chest infection
  • other infection
  • paralytic ileus
within 12 weeks after surgery
Serious adverse events
Time Frame: within 12 weeks after surgery
  • respiratory failure requiring ventilation
  • renal failure requiring dialysis
  • cardiac failure
  • myocardial infarction
  • anastomotic leakage requiring surgery
  • anastomotic leakage requiring drainage
  • bowel obstruction/stricture requiring surgery
  • abdominal wall dehiscence requiring surgery
  • readmission within 30 days after surgery
  • reoperation within 30 days after surgery
  • mortality during surgery or within 30 days after surgery
within 12 weeks after surgery
Adverse events related to acupuncture
Time Frame: within 12 weeks after surgery
Expected or unexpected adverse events that are considered to be associated with acupuncture treatments.
within 12 weeks after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to enhanced recovery program after surgery
Time Frame: at 1 week after surgery (an expected day of discharge)
Number of patients who discharge the hospital at the expected day as planned
at 1 week after surgery (an expected day of discharge)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gi Young Yang, PhD, Korean Medicine Hospital, Pusan National University
  • Principal Investigator: Kyung Mo Son, PhD, Pusan National University Yangsan Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

March 1, 2015

First Submitted That Met QC Criteria

March 9, 2015

First Posted (Estimate)

March 13, 2015

Study Record Updates

Last Update Posted (Estimate)

June 28, 2016

Last Update Submitted That Met QC Criteria

June 25, 2016

Last Verified

June 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe